# Triamcinolone Levels in Cochlear Perilymph

> **NCT03248856** · PHASE1 · COMPLETED · sponsor: **Christoph Arnoldner** · enrollment: 40 (actual)

## Conditions studied

- Cochlear Hearing Loss

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT03248856
- **Lead sponsor:** Christoph Arnoldner
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-02
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03248856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03248856, "Triamcinolone Levels in Cochlear Perilymph". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03248856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*